The aftermath of SARS-CoV-2 in NICU: saving or checking accounts? Projected cost-effectiveness analysis

被引:1
|
作者
Galderisi, Alfonso [1 ]
Lolli, Elisabetta [1 ]
Cavicchiolo, Maria Elena [1 ]
Bonadies, Luca [1 ]
Trevisanuto, Daniele [1 ]
Baraldi, Eugenio [1 ]
机构
[1] Univ Hosp Padova, Dept Womens & Childrens Hlth, Via N Giustiniani 3, I-35128 Padua, Italy
关键词
Preterm infant; Neonatal intensive care unit; SARS-CoV-2; COVID-19; Cost-effectiveness; Screening;
D O I
10.1007/s00431-020-03884-1
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
In the aftermath of the SARS-CoV-2 pandemic, we revised the cost-effectiveness of the exploited interventions in neonatal intensive care unit, to redefine future strategies for hospital management. Costs were revised with respect to the lockdown R0 or under different R0 scenarios to estimate the cost-effectiveness of the screening program adopted. Weekly nasopharyngeal swabs for parents, neonates, and personnel were the major cost during the pandemic, although they effectively reduced the number of cases in our unit. Conclusion: Parents and healthcare personnel testing appears to be an effective strategy due to the high number of contact they have within the hospital environment and outside, able to minimize the cases within our unit. What is Known: center dot Costs of universal COVID-19 tests for parents, neonates, and NICU personnel have not been evaluated during the COVID-19 pandemic in neonatal intensive care unit in Europe. What is New: center dot Weekly nasopharyngeal swabs for parents, neonates, and personnel were the major cost during the COVID-19 pandemic in NICU. center dot Parents and healthcare personnel testing was effective to reduce costs related to COVID-19 due to the high number of contact they have within the hospital environment and outside.
引用
收藏
页码:1631 / 1635
页数:5
相关论文
共 50 条
  • [41] On the effectiveness of the search and find method to suppress spread of SARS-CoV-2
    Sugawara, Hirotaka
    PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES, 2021, 97 (01): : 22 - 49
  • [42] Effectiveness of and Immune Responses to SARS-CoV-2 mRNA Vaccines and Their Mechanisms
    Gohda, Eiichi
    JOURNAL OF DISASTER RESEARCH, 2022, 17 (01) : 7 - 20
  • [43] Effectiveness of antithrombotic prophylaxis in hospitalised patients with SARS-CoV-2 infection
    Quiros Ambel, Helena
    Crespo-Robledo, Paloma
    Arribalzaga Juaristi, Karmele
    Plo-Seco, Isabel
    Martinez Simon, Jose Javier
    Perez Fernandez, Elia
    Perez Encinas, Monserrat
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2023, 30 (05) : 264 - 267
  • [44] Effectiveness of Face Masks in Preventing Airborne Transmission of SARS-CoV-2
    Ueki, Hiroshi
    Furusawa, Yuri
    Iwatsuki-Horimoto, Kiyoko
    Imai, Masaki
    Kabata, Hiroki
    Nishimura, Hidekazu
    Kawaoka, Yoshihiro
    MSPHERE, 2020, 5 (05)
  • [45] Modeling the effectiveness of olfactory testing to limit SARS-CoV-2 transmission
    Larremore, Daniel B.
    Toomre, Derek
    Parker, Roy
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [46] Theoretical Framework for Retrospective Studies of the Effectiveness of SARS-CoV-2 Vaccines
    Lewnard, Joseph A.
    Patel, Manish M.
    Jewell, Nicholas P.
    Verani, Jennifer R.
    Kobayashi, Miwako
    Tenforde, Mark W.
    Dean, Natalie E.
    Cowling, Benjamin J.
    Lopman, Benjamin A.
    EPIDEMIOLOGY, 2021, 32 (04) : 508 - 517
  • [47] Phylogenetic analysis of SARS-CoV-2 genomes in Turkey
    Adebali, Ogun
    Bircan, Aylin
    Circi, Defne
    Islek, Burak
    Kilinc, Zeynep
    Selcuk, Berkay
    Turhan, Berk
    TURKISH JOURNAL OF BIOLOGY, 2020, 44 (03) : 146 - 156
  • [48] Identification and computational analysis of mutations in SARS-CoV-2
    Dey, Tathagata
    Chatterjee, Shreyans
    Manna, Smarajit
    Nandy, Ashesh
    Basak, Subhas C.
    COMPUTERS IN BIOLOGY AND MEDICINE, 2021, 129
  • [49] An updated analysis of variations in SARS-CoV-2 genome
    Ugurel, Osman Mutluhan
    Ata, Oguz
    Turgut-Balik, Dilek
    TURKISH JOURNAL OF BIOLOGY, 2020, 44 (03) : 157 - 167
  • [50] Functional and druggability analysis of the SARS-CoV-2 proteome
    Cavasotto, Claudio N.
    Sanchez Lamas, Maximiliano
    Maggini, Julian
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 890